Capital International, Inc. Vertex Pharmaceuticals Inc Transaction History

Capital International, Inc.

$7.57 Billion
Q3 2024

A detailed history of Capital International, Inc. transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Capital International, Inc. holds 110,353 shares of VRTX stock, worth $44.7 Million. This represents 0.68% of its overall portfolio holdings.

Number of Shares

110,353

Previous 106,182 3.93%

Holding current value

$44.7 Million

Previous $49.8 Million 3.12%

% of portfolio

0.68%

Previous 0.69%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 13, 2024	BUY	$460.0 - $505.78 $1.92 Million - $2.11 Million	4,171 Added 3.93%	110,353 $51.3 Million
Q2 2024 Aug 13, 2024	BUY	$392.81 - $485.53 $3.01 Million - $3.72 Million	7,657 Added 7.77%	106,182 $49.8 Million
Q1 2024 May 14, 2024	BUY	$407.69 - $446.08 $8.35 Million - $9.14 Million	20,482 Added 26.24%	98,525 $41.2 Million
Q4 2023 Feb 13, 2024	BUY	$343.0 - $410.68 $5.52 Million - $6.61 Million	16,102 Added 26.0%	78,043 $31.8 Million
Q3 2023 Nov 13, 2023	BUY	$338.18 - $362.46 $1.88 Million - $2.01 Million	5,552 Added 9.85%	61,941 $21.5 Million
Q2 2023 Aug 11, 2023	BUY	$314.42 - $351.91 $5.59 Million - $6.25 Million	17,771 Added 46.02%	56,389 $19.8 Million
Q1 2023 May 15, 2023	BUY	$283.23 - $323.1 $336,194 - $383,519	1,187 Added 3.17%	38,618 $12.2 Million
Q4 2022 Feb 14, 2023	SELL	$285.76 - $321.48 $1.54 Million - $1.73 Million	-5,379 Reduced 12.56%	37,431 $10.8 Million
Q3 2022 Nov 14, 2022	SELL	$273.83 - $305.53 $4.55 Million - $5.08 Million	-16,624 Reduced 27.97%	42,810 $12.4 Million
Q2 2022 Aug 15, 2022	SELL	$234.96 - $292.55 $146,145 - $181,966	-622 Reduced 1.04%	59,434 $16.7 Million
Q1 2022 May 16, 2022	SELL	$221.42 - $260.97 $10.4 Million - $12.3 Million	-47,117 Reduced 43.96%	60,056 $15.7 Million
Q4 2021 Feb 14, 2022	BUY	$177.01 - $223.45 $2.4 Million - $3.03 Million	13,572 Added 14.5%	107,173 $23.5 Million
Q3 2021 Nov 15, 2021	SELL	$181.39 - $202.99 $3.94 Million - $4.4 Million	-21,698 Reduced 18.82%	93,601 $17 Million
Q2 2021 Aug 16, 2021	SELL	$187.49 - $221.1 $120,743 - $142,388	-644 Reduced 0.56%	115,299 $23.2 Million
Q1 2021 May 14, 2021	SELL	$207.02 - $241.31 $21 Million - $24.5 Million	-101,543 Reduced 46.69%	115,943 $24.9 Million
Q4 2020 Feb 16, 2021	BUY	$207.01 - $276.09 $319,830 - $426,559	1,545 Added 0.72%	217,486 $51.4 Million
Q3 2020 Nov 13, 2020	BUY	$255.65 - $303.1 $3.01 Million - $3.57 Million	11,780 Added 5.77%	215,941 $58.8 Million
Q2 2020 Aug 14, 2020	BUY	$225.48 - $295.8 $9.59 Million - $12.6 Million	42,547 Added 26.33%	204,161 $59.3 Million
Q1 2020 May 15, 2020	BUY	$199.77 - $247.81 $4.48 Million - $5.55 Million	22,414 Added 16.1%	161,614 $38.5 Million
Q4 2019 Feb 18, 2020	BUY	$166.71 - $223.91 $23.2 Million - $31.2 Million	139,200 New	139,200 $30.5 Million
Q3 2019 Nov 14, 2019	SELL	$166.23 - $187.09 $3.26 Million - $3.67 Million	-19,615 Closed	0 $0
Q2 2019 Aug 14, 2019	BUY	$164.61 - $190.37 $3.23 Million - $3.73 Million	19,615 New	19,615 $3.6 Million

Others Institutions Holding VRTX

# of Institutions

1,724

Shares Held

221M

Call Options Held

1.58M

Put Options Held

1.36M

View Full List

About VERTEX PHARMACEUTICALS INC

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $104B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

More about VRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital International, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Capital International, Inc. with notifications on news.

Account

Capital International, Inc. Vertex Pharmaceuticals Inc Transaction History